RESUMEN
Deposition of misfolded α-synuclein (αsyn) in the enteric nervous system (ENS) is found in multiple neurodegenerative diseases. It is hypothesized that ENS synucleinopathy contributes to both the pathogenesis and non-motor morbidity in Parkinson's Disease (PD), but the cellular and molecular mechanisms that shape enteric histopathology and dysfunction are poorly understood. Here, we demonstrate that ENS-resident macrophages, which play a critical role in maintaining ENS homeostasis, initially respond to enteric neuronal αsyn pathology by upregulating machinery for complement-mediated engulfment. Pharmacologic depletion of ENS-macrophages or genetic deletion of C1q enhanced enteric neuropathology. Conversely, C1q deletion ameliorated gut dysfunction, indicating that complement partially mediates αsyn-induced gut dysfunction. Internalization of αsyn led to increased endo-lysosomal stress that resulted in macrophage exhaustion and temporally correlated with the progression of ENS pathology. These novel findings highlight the importance of enteric neuron-macrophage interactions in removing toxic protein aggregates that putatively shape the earliest stages of PD in the periphery.
RESUMEN
Aggregated alpha-synuclein proteins form brain lesions that are hallmarks of neurodegenerative synucleinopathies, and oxidative stress has been implicated in the pathogenesis of some of these disorders. Using antibodies to specific nitrated tyrosine residues in alpha-synuclein, we demonstrate extensive and widespread accumulations of nitrated alpha-synuclein in the signature inclusions of Parkinson's disease, dementia with Lewy bodies, the Lewy body variant of Alzheimer's disease, and multiple system atrophy brains. We also show that nitrated alpha-synuclein is present in the major filamentous building blocks of these inclusions, as well as in the insoluble fractions of affected brain regions of synucleinopathies. The selective and specific nitration of alpha-synuclein in these disorders provides evidence to directly link oxidative and nitrative damage to the onset and progression of neurodegenerative synucleinopathies.
Asunto(s)
Encéfalo/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Enfermedades Neurodegenerativas/metabolismo , Enfermedades Neurodegenerativas/patología , Estrés Oxidativo , Tirosina/análogos & derivados , Tirosina/metabolismo , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/patología , Anticuerpos Monoclonales , Western Blotting , Encéfalo/patología , Química Encefálica , Ensayo de Inmunoadsorción Enzimática , Técnica del Anticuerpo Fluorescente , Humanos , Inmunohistoquímica , Cuerpos de Lewy/química , Enfermedad por Cuerpos de Lewy/metabolismo , Enfermedad por Cuerpos de Lewy/patología , Microscopía Inmunoelectrónica , Atrofia de Múltiples Sistemas/metabolismo , Atrofia de Múltiples Sistemas/patología , Proteínas del Tejido Nervioso/análisis , Proteínas del Tejido Nervioso/inmunología , Neuronas/química , Neuronas/metabolismo , Neuronas/ultraestructura , Enfermedad de Parkinson/metabolismo , Enfermedad de Parkinson/patología , Sinucleínas , Tirosina/análisis , Tirosina/inmunología , alfa-SinucleínaRESUMEN
Parkinson's disease (PD) is a neurodegenerative disease characterized by the selective demise of specific neuronal populations leading to impairment of motor functions. Recent genetic studies have uncovered several genes involved in inherited forms of the disease. These gene products are implicated in the biochemical pathways underlying the etiology of sporadic PD. Mutations in the parkin gene causal of autosomal recessive juvenile parkinsonism highlight that ubiquitin-mediated proteolysis may play an important role in the pathobiology of PD.
Asunto(s)
Cisteína Endopeptidasas/metabolismo , Ligasas/fisiología , Complejos Multienzimáticos/metabolismo , Proteínas del Tejido Nervioso/fisiología , Enfermedad de Parkinson/genética , Ubiquitina-Proteína Ligasas , Edad de Inicio , Secuencias de Aminoácidos , Animales , Cromosomas Humanos Par 6/genética , Drosophila melanogaster/genética , Drosophila melanogaster/metabolismo , Predisposición Genética a la Enfermedad , Humanos , Cuerpos de Lewy/metabolismo , Ligasas/deficiencia , Ligasas/genética , Ratones , Ratones Transgénicos , Modelos Biológicos , Mutación , Proteínas del Tejido Nervioso/deficiencia , Proteínas del Tejido Nervioso/genética , Estrés Oxidativo , Enfermedad de Parkinson/epidemiología , Enfermedad de Parkinson/metabolismo , Complejo de la Endopetidasa Proteasomal , Pliegue de Proteína , Ratas , Relación Estructura-Actividad , Sustancia Negra/metabolismo , Sinucleínas , Ubiquitina/fisiologíaRESUMEN
Brain lesions containing filamentous and aggregated alpha-synuclein are hallmarks of neurodegenerative synucleinopathies. Oxidative stress has been implicated in the formation of these lesions. Using HEK 293 cells stably transfected with wild-type and mutant alpha-synuclein, we demonstrated that intracellular generation of nitrating agents results in the formation of alpha-synuclein aggregates. Cells were exposed simultaneously to nitric oxide- and superoxide-generating compounds, and the intracellular formation of peroxynitrite was demonstrated by monitoring the oxidation of dihydrorhodamine 123 and the nitration of alpha-synuclein. Light microscopy using antibodies against alpha-synuclein and electron microscopy revealed the presence of perinuclear aggregates under conditions in which peroxynitrite was generated but not when cells were exposed to nitric oxide- or superoxide-generating compounds separately. alpha-Synuclein aggregates were observed in 20-30% of cells expressing wild-type or A53T mutant alpha-synuclein and in 5% of cells expressing A30P mutant alpha-synuclein. No evidence of synuclein aggregation was observed in untransfected cells or cells expressing beta-synuclein. In contrast, selective inhibition of the proteasome resulted in the formation of aggregates detected with antibodies to ubiquitin in the majority of the untransfected cells and cells expressing alpha-synuclein. However, alpha-synuclein did not colocalize with these aggregates, indicating that inhibition of the proteasome does not promote alpha-synuclein aggregation. In addition, proteasome inhibition did not alter the steady-state levels of alpha-synuclein, but addition of the lysosomotropic agent ammonium chloride significantly increased the amount of alpha-synuclein, indicating that lysosomes are involved in degradation of alpha-synuclein. Our data indicate that nitrative and oxidative insult may initiate pathogenesis of alpha-synuclein aggregates.
Asunto(s)
Líquido Intracelular/metabolismo , Riñón/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Cloruro de Amonio/metabolismo , Cloruro de Amonio/farmacocinética , Línea Celular , Cisteína Endopeptidasas , Inhibidores Enzimáticos/farmacología , Humanos , Cuerpos de Inclusión/metabolismo , Riñón/citología , Riñón/efectos de los fármacos , Lisosomas/metabolismo , Sustancias Macromoleculares , Complejos Multienzimáticos/antagonistas & inhibidores , Proteínas del Tejido Nervioso/genética , Enfermedades Neurodegenerativas/metabolismo , Nitratos/metabolismo , Óxido Nítrico/biosíntesis , Óxido Nítrico/farmacología , Oxidantes/farmacología , Complejo de la Endopetidasa Proteasomal , Unión Proteica/efectos de los fármacos , Unión Proteica/fisiología , Superóxidos/metabolismo , Superóxidos/farmacología , Sinucleínas , Transfección , Ubiquitinas/metabolismo , alfa-Sinucleína , Sinucleína betaRESUMEN
Although alpha-synuclein (alpha-syn) has been implicated as a major component of the abnormal filaments that form glial cytoplasmic inclusions (GCIs) in multiple system atrophy (MSA), it is uncertain if GCIs are homogenous and contain full-length alpha-syn. Since this has implications for hypotheses about the pathogenesis of GCIs, we used a novel panel of antibodies to defined regions throughout alpha-syn in immunohistochemical epitope mapping studies of GCIs in MSA brains. Although the immunostaining profile of GCIs with these antibodies was similar for all MSA brains, there were significant differences in the immunoreactivity of the alpha-syn epitopes detected in GCIs. Notably, carboxy-terminal alpha-syn epitopes were immunodominant in GCIs, but the entire panel of antibodies immunostained cortical Lewy bodies (LBs) in dementia with LBs brain with similar intensity. While the distribution of alpha-syn labeled GCIs paralleled that previously reported using silver stains, antibodies to carboxy-terminal alpha-syn epitopes revealed a previously undescribed burden of GCIs in the MSA hippocampal formation. Finally, Western blots demonstrated detergent insoluble monomeric and high-molecular weight alpha-syn species in GCI rich MSA cerebellar white matter. Collectively, these data indicate that alpha-syn is a prominent component of GCIs in MSA, and that GCIs and LBs may result from cell type specific conformational or post-translational permutations in alpha-syn.
Asunto(s)
Encéfalo/patología , Atrofia de Múltiples Sistemas/patología , Proteínas del Tejido Nervioso/análisis , Anciano , Anciano de 80 o más Años , Anticuerpos , Anticuerpos Monoclonales , Ganglios Basales/patología , Cerebelo/patología , Femenino , Hipocampo/patología , Humanos , Inmunohistoquímica , Masculino , Bulbo Raquídeo/patología , Mesencéfalo/patología , Persona de Mediana Edad , Puente/patología , Sinucleínas , alfa-SinucleínaRESUMEN
Synucleins are a family of small proteins that are predominantly expressed in neurons. The functions of the synucleins are not entirely understood, but they have been implicated in the pathogenesis of several neurodegenerative diseases. Our data show that alpha-, beta- or gamma-synuclein suppresses the aggregation of thermally denatured alcohol dehydrogenase and chemically denatured insulin. The A53T but not the A30P mutant alpha-synuclein was able to inhibit the aggregation of insulin and the chaperone-like activity of alpha-synuclein was lost upon removal of its C-terminal residues 98-140. These results demonstrate that synucleins with the exception of the A30P mutant possess chaperone-like activity.
Asunto(s)
Chaperonas Moleculares/farmacología , Proteínas del Tejido Nervioso/farmacología , Alcohol Deshidrogenasa/química , Disulfuros/química , Ditiotreitol/farmacología , Escherichia coli , Calor , Humanos , Insulina/química , Mutación , Proteínas del Tejido Nervioso/genética , Desnaturalización Proteica , Proteínas Recombinantes/farmacología , Ribonucleasa Pancreática/química , Sinucleínas , alfa-Sinucleína , gamma-SinucleínaRESUMEN
Treatment of PC12 cells or dorsal root ganglion neurons with the protease inhibitor, N-Acetyl-Leu-Leu-norleucinal, stimulated phosphorylation of the mid-sized and heavy neurofilament subunits and caused the heavy subunit in the perikarya of dorsal root ganglion neurons to become hyperphosphorylated. The closely related inhibitor, N-Acetyl-Leu-Leu-methioninal, did not produce a similar effect. Okadaic acid increased the phosphorylation state of the heavy neurofilament subunit in PC12 cells in a fashion similar to N-Acetyl-Leu-Leu-norleucinal and the effect of both compounds together was greater than for either one alone. There was no increase in cyclin-dependent kinase 5-immunoprecipitable histone H1 kinase activity in PC12 cells treated with N-Acetyl-Leu-Leu-norleucinal despite the presence of enzyme protein. The present study demonstrates that a protease inhibitor can induce the hyperphosphorylation of neurofilament subunits to a level normally seen only in axons. This suggests that perturbations in intracellular proteolysis may lead to the accumulation of phosphorylated neurofilament epitopes in neuronal perikarya in certain pathological states. The results also show that the carboxy-terminal tail domains of the two largest neurofilament subunits are phosphorylated even when cyclin dependent kinase 5 is inactive, indicating that other neuronal kinases are involved in the phosphorylation of Lys-Ser-Pro repeats.
Asunto(s)
Ganglios Espinales/metabolismo , Leupeptinas/farmacología , Proteínas de Neurofilamentos/metabolismo , Neuronas/metabolismo , Secuencia de Aminoácidos , Animales , Western Blotting , Electroforesis en Gel de Poliacrilamida , Ganglios Espinales/citología , Ganglios Espinales/efectos de los fármacos , Humanos , Concentración de Iones de Hidrógeno , Datos de Secuencia Molecular , Neuronas/efectos de los fármacos , Neuronas/enzimología , Células PC12 , Fosforilación/efectos de los fármacos , Pruebas de Precipitina , Proteínas Quinasas/metabolismo , Ratas , Estimulación QuímicaRESUMEN
The expression and Triton X-100 (Triton) solubility of neuronal intermediate filament proteins were determined in the developing rat cerebral cortex. The level of expression of alpha-internexin was unchanged from embryonic day 15 (E15) to postnatal day 15 (P15), whereas expression of the mid-sized neurofilament subunit increased continually during this interval concomitant with a reduction in Triton solubility of the two proteins. The low molecular weight neurofilament subunit, first barely detected at P2, was largely insoluble in Triton from the initial time point that its solubility could be assayed, at P5, to P15. Similar expression patterns and Triton solubility profiles were obtained for neuronal intermediate filament proteins in cultured neurons from E15 cerebral cortex. These results suggest that alpha-internexin is expressed earlier than neurofilament proteins to provide a more plastic network in the early developing brain. The incorporation of neurofilament proteins apparently results in the formation of the more stable intermediate filament network found in mature neurons.
Asunto(s)
Proteínas Portadoras/metabolismo , Corteza Cerebral/crecimiento & desarrollo , Corteza Cerebral/metabolismo , Proteínas de Neurofilamentos/metabolismo , Factores de Edad , Animales , Proteínas de Filamentos Intermediarios/metabolismo , Ratas , Ratas Sprague-DawleyAsunto(s)
Exposición a Riesgos Ambientales/efectos adversos , Enfermedad de Parkinson Secundaria/inducido químicamente , Plaguicidas/toxicidad , Animales , Humanos , Cuerpos de Lewy/metabolismo , Cuerpos de Lewy/patología , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Enfermedad de Parkinson/genética , Enfermedad de Parkinson/metabolismo , Rotenona/toxicidad , SinucleínasRESUMEN
The synucleinopathies are neurodegenerative disorders defined by inclusions composed of aberrantly fibrillized alpha-synuclein, but factors contributing to this process remain largely unknown. The authors examined the glucocerebrosidase gene in 75 autopsy specimens with different synucleinopathies and identified mutations in 23% of cases of dementia with Lewy bodies, expanding on previous findings in subjects with Parkinson disease. Mutations in this lysosomal protein may interfere with the clearance or promote aggregation of alpha-synuclein.
Asunto(s)
Glucosilceramidasa/genética , Enfermedad por Cuerpos de Lewy/genética , Mutación , Adulto , Anciano , Anciano de 80 o más Años , Asparagina/genética , Autopsia , Encéfalo/patología , Análisis Mutacional de ADN/métodos , Femenino , Humanos , Isoleucina/genética , Enfermedad por Cuerpos de Lewy/metabolismo , Enfermedad por Cuerpos de Lewy/patología , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/genética , Enfermedad de Parkinson/patología , Factores de Riesgo , Sinucleínas/metabolismo , Treonina/genéticaRESUMEN
The aim of this study was to assess the effects of low concentrations of okadaic acid (OA) on neurite outgrowth and cellular integrity in cultures of dissociated dorsal root ganglion (DRG) neurons. The complete and fully reversible arrest of neurite outgrowth was achieved at 1 nM OA, thus ruling out the involvement of protein phosphatase 1 in the observed inhibitory effect. OA at 0.5 nM did not completely block neurite outgrowth, although it reduced the rate of growth by about one third. Protein phosphorylation and the integrity of microtubules and neurofilaments in neuron-enriched cultures were unaffected by 1 nM OA. The rate of synthesis of the low-molecular-weight neurofilament subunit (NFL) was also unchanged by OA treatment. Antimitotic agents used to eliminate proliferating cells did not alter the rate of neurite elongation. Since 1 nM OA does not suffice to inhibit neuronal protein phosphatase 2A fully, owing to the high concentration of this enzyme in neurons, we propose that the inhibitor is affecting a neuronal compartment that contains low levels of the phosphatase. This putative compartment is likely to be located in neurites, which were shown to contain levels of protein phosphatase 2A that were two- to threefold lower than in neuronal perikarya.
Asunto(s)
División Celular/efectos de los fármacos , Ganglios Espinales/efectos de los fármacos , Ácido Ocadaico/farmacología , Animales , Células Cultivadas/efectos de los fármacos , Ratas , Ratas Sprague-DawleyRESUMEN
The aberrant phosphorylation of the neurofilament high molecular weight subunit (NFH) in the neuronal perikaryon is a common feature of several neurological diseases. We demonstrated a strong correlation between hyperphosphorylation of the NFH carboxyl-terminal domain and activation of stress-activated protein kinase (SAPK) -gamma in PC12 cells. Agents that activated SAPKgamma in PC12 cells also caused the hyperphosphorylation of perikaryal NFH in cultured dorsal root ganglion neurons. The NFH carboxyl-terminal domain was phosphorylated by SAPKgamma in vitro, and the use of peptide substrates indicated that this event occurred preferentially at KSPXE motifs. We propose that SAPKgamma, perhaps in concert with other SAPKs, is involved in the abnormal phosphorylation of perikaryal NFH. This finding could lead to new insights into the etiology of several neurological diseases.
Asunto(s)
Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Leupeptinas/farmacología , Proteínas Quinasas Activadas por Mitógenos , Proteínas de Neurofilamentos/metabolismo , Proteínas Quinasas/metabolismo , Estrés Fisiológico/metabolismo , Secuencia de Aminoácidos , Animales , Activación Enzimática/efectos de los fármacos , Técnica del Anticuerpo Fluorescente Indirecta , Ganglios Espinales/metabolismo , Proteína Quinasa 1 Activada por Mitógenos , Proteína Quinasa 12 Activada por Mitógenos , Proteína Quinasa 3 Activada por Mitógenos , Datos de Secuencia Molecular , Factores de Crecimiento Nervioso/farmacología , Neuronas/metabolismo , Neuronas/ultraestructura , Oligopéptidos/farmacología , Células PC12 , Fosforilación , Inhibidores de Proteasas/farmacología , Ratas , Relación Estructura-ActividadRESUMEN
We previously reported that activation of protein kinase A in cultured rat dorsal root ganglion neurons, treated concomitantly with low concentrations of okadaic acid that selectively inhibit protein phosphatase-2A, enhanced the Triton X-100 solubility of neurofilament triplet proteins. We now show that peripherin and alpha-internexin follow the same fragmentation profile as the neurofilament subunits, consistent with the notion that all five cytoplasmic intermediate filament proteins in these neurons form an integrated filamentous network whose assembly can be modulated by protein kinase A. Similar to the situation previously observed for the light neurofilament subunit, there was a strong correlation between phosphorylation of the amino-terminal head domain of peripherin and filament fragmentation. In contrast, insignificant levels of 32P were incorporated into alpha-internexin under conditions promoting disassembly, indicating that phosphorylation of this protein is not involved directly in filament fragmentation. The situation for the mid-sized neurofilament subunit (NFM) was not as clear-cut. Phosphopeptide mapping of NFM revealed many head and tail domain phosphorylation sites. However, changes in NFM head domain phosphorylation under conditions promoting filament disassembly were not as pronounced as for peripherin.
Asunto(s)
Ganglios Espinales/fisiología , Proteínas de Filamentos Intermediarios/fisiología , Glicoproteínas de Membrana , Neuronas/fisiología , Animales , Proteínas Portadoras/fisiología , Células Cultivadas , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Activación Enzimática/fisiología , Inhibidores Enzimáticos/farmacología , Ganglios Espinales/citología , Peso Molecular , Proteínas del Tejido Nervioso/fisiología , Proteínas de Neurofilamentos/química , Proteínas de Neurofilamentos/fisiología , Ácido Ocadaico/farmacología , Mapeo Peptídico , Periferinas , Fosforilación , RatasRESUMEN
The high-molecular-mass neurofilament subunit (NFH) is normally hypophosphorylated in the neuronal perikaryon and undergoes extensive phosphorylation after entering the initial axon segment. Aberrant hyperphosphorylation of perikaryal NFH is a common feature of many neurological diseases. In a previous study (), we demonstrated a correlation between phosphorylation of perikaryal NFH and induction of stress-activated protein kinase (SAPK)-gamma. In this report, we present direct evidence showing that the in vivo activation of SAPKs by an upstream activator (MEKK-1) caused extensive NFH phosphorylation. We also show that stress-activated p38 kinases were not involved in the phosphorylation of perikaryal NFH in cultured dorsal root ganglion neurons and that this process was reversible. SAPKgamma was shown to be located in both the cell body and the neurites of the cultured neurons, suggesting that it is likely to be involved in the phosphorylation of cytoplasmic substrates. These could include neuritic NFH, which is highly phosphorylated despite the demonstrated lack of cyclin-dependent kinase-5 activity in these neurons. Neuritic NFH was also highly phosphorylated in neuronal cultures devoid of Schwann cells, indicating that this form of post-translational modification does not require cues stemming from Schwann cell-axon contacts. Collectively, these findings provide significant new insights into mechanisms involved in NFH phosphorylation in normal neurons and in disease states characterized by aberrant phosphorylation of neurofilaments.
Asunto(s)
Quinasas Ciclina-Dependientes , Proteínas Quinasas Activadas por Mitógenos , Proteínas de Neurofilamentos/metabolismo , Neuronas/enzimología , Proteínas Quinasas/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Células 3T3/fisiología , Animales , Axones/química , Axones/enzimología , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Células Cultivadas , Quinasa 5 Dependiente de la Ciclina , Ganglios Espinales/química , Ganglios Espinales/citología , Ganglios Espinales/enzimología , Ratones , Quinasas de Proteína Quinasa Activadas por Mitógenos , Proteínas de Neurofilamentos/química , Neuronas/química , Neuronas/ultraestructura , Fosforilación , Estructura Terciaria de Proteína , Ratas , Estrés Fisiológico/metabolismo , Transfección , Proteínas Quinasas p38 Activadas por MitógenosRESUMEN
Intracellular proteinaceous aggregates are hallmarks of many common neurodegenerative disorders, and recent studies have shown that alpha-synuclein is a major component of several pathological intracellular inclusions, including Lewy bodies in Parkinson's disease (PD) and glial cell inclusions in multiple system atrophy. However, the molecular mechanisms underlying alpha-synuclein aggregation into filamentous inclusions remain unknown. Since oxidative and nitrative stresses are potential pathogenic mediators of PD and other neurodegenerative diseases, we asked if oxidative and/or nitrative events alter alpha-synuclein and induce it to aggregate. Here we show that exposure of human recombinant alpha-synuclein to nitrating agents (peroxynitrite/CO(2) or myeloperoxidase/H(2)O(2)/nitrite) induces formation of nitrated alpha-synuclein oligomers that are highly stabilized due to covalent cross-linking via the oxidation of tyrosine to form o,o'-dityrosine. We also demonstrate that oxidation and nitration of pre-assembled alpha-synuclein filaments stabilize these filaments to withstand denaturing conditions and enhance formation of SDS-insoluble, heat-stable high molecular mass aggregates. Thus, these data suggest that oxidative and nitrative stresses are involved in mechanisms underlying the pathogenesis of Lewy bodies and glial cell inclusions in PD and multiple system atrophy, respectively, as well as alpha-synuclein pathologies in other synucleinopathies.
Asunto(s)
Proteínas del Tejido Nervioso/metabolismo , Enfermedades Neurodegenerativas/etiología , Nitratos/metabolismo , Estrés Oxidativo , Tirosina/análogos & derivados , Electroforesis en Gel de Poliacrilamida , Humanos , Polímeros/metabolismo , Proteínas Recombinantes/metabolismo , Sinucleínas , Tirosina/metabolismo , alfa-SinucleínaRESUMEN
Neuronal and oligodendrocytic aggregates of fibrillar alpha-synuclein define several diseases of the nervous system. It is likely that these inclusions impair vital metabolic processes and compromise viability of affected cells. Here, we report that a 12-amino acid stretch ((71)VTGVTAVAQKTV(82)) in the middle of the hydrophobic domain of human alpha-synuclein is necessary and sufficient for its fibrillization based on the following observations: 1) human beta-synuclein is highly homologous to alpha-synuclein but lacks these 12 residues, and it does not assemble into filaments in vitro; 2) the rate of alpha-synuclein polymerization in vitro decreases after the introduction of a single charged amino acid within these 12 residues, and a deletion within this region abrogates assembly; 3) this stretch of 12 amino acids appears to form the core of alpha-synuclein filaments, because it is resistant to proteolytic digestion in alpha-synuclein filaments; and 4) synthetic peptides corresponding to this 12-amino acid stretch self-polymerize to form filaments, and these peptides promote fibrillization of full-length human alpha-synuclein in vitro. Thus, we have identified key sequence elements necessary for the assembly of human alpha-synuclein into filaments, and these elements may be exploited as targets for the design of drugs that inhibit alpha-synuclein fibrillization and might arrest disease progression.
Asunto(s)
Proteínas del Tejido Nervioso/metabolismo , Secuencia de Aminoácidos , Humanos , Datos de Secuencia Molecular , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/ultraestructura , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Fragmentos de Péptidos/metabolismo , Unión Proteica , Conformación Proteica , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/ultraestructura , Sinucleínas , alfa-Sinucleína , Sinucleína betaRESUMEN
alpha-Synuclein is a soluble presynaptic protein which is pathologically redistributed within intracellular lesions characteristic of several neurodegenerative diseases. Here we demonstrate that wild type and two mutant forms of alpha-synuclein linked to familial Parkinson's disease (Ala30 --> Pro and Ala53 --> Thr) self-aggregate and assemble into 10-19-nm-wide filaments with distinct morphologies under defined in vitro conditions. Immunogold labeling demonstrates that the central region of all these filaments are more robustly labeled than the N-terminal or C-terminal regions, suggesting that the latter regions are buried within the filaments. Since in vitro generated alpha-synuclein filaments resemble the major ultrastructural elements of authentic Lewy bodies that are hallmark lesions of Parkinson's disease, we propose that self-aggregating alpha-synuclein is the major subunit protein of these filamentous lesions.
Asunto(s)
Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Conformación Proteica , Sustitución de Aminoácidos , Citoesqueleto/ultraestructura , Detergentes , Humanos , Microscopía Electrónica , Enfermedad de Parkinson/genética , Dodecil Sulfato de Sodio , Solubilidad , Sinucleínas , alfa-SinucleínaRESUMEN
PC12 cells are well characterized for their ability to differentiate into neuronal-like cells when challenged with nerve growth factor. It has been reported that the calpain and proteasome inhibitor N-acetyl-Leu-Leu-norleucinal (CI) is also able to induce neurite outgrowth in PC12 cells. In this study, we report that the inhibitor of proteasomal chymotrypsin-like activity, carbobenzoxy-Ile-Glu-(O-tert-butyl)-Ala-Leu-aldehyde (PSI), can also induce differentiation of PC12 cells. Induction of neurite outgrowth with PSI, CI, or its close analogue, carbobenzoxy-Leu-Leu-leucinal (MG132), was associated with stress-activated protein kinase (SAPK) activation. Neurite formation induced by protease inhibition was independent of mitogen-activated protein kinase/extracellular signal-regulated kinase, p38/reactivating kinase, or phosphatidylinositol 3-kinase activities. The exact mechanism by which protease inhibition activates SAPKs remains to be elucidated; however, our results suggest that the SAPK signal transduction cascade may be an alternative and/or parallel pathway in the regulation of neuronal differentiation.
Asunto(s)
Proteínas Quinasas Activadas por Mitógenos , Neuritas/efectos de los fármacos , Inhibidores de Proteasas/farmacología , Proteínas Quinasas/metabolismo , Animales , Western Blotting , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Diferenciación Celular/efectos de los fármacos , Electroforesis en Gel de Poliacrilamida , Activación Enzimática/fisiología , Leupeptinas/farmacología , Proteína Quinasa 12 Activada por Mitógenos , Neuritas/enzimología , Células PC12 , Fosfatidilinositol 3-Quinasas/metabolismo , Pruebas de Precipitina , Inhibidores de Proteínas Quinasas , Ratas , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Proteínas Quinasas p38 Activadas por MitógenosRESUMEN
The activation of cyclic AMP-dependent protein kinase (PKA) in rat dorsal root ganglion (DRG) cultures increased phosphorylation of the low-molecular-mass neurofilament subunit (NFL) at a site previously identified as Ser55 but had no effect on neurofilament integrity. When PKA was activated in DRG cultures treated with 20-250 nM okadaic acid, neurofilament fragmentation was enhanced, and there was a corresponding increase in phosphorylation of NFL at a novel site. This site was also phosphorylated by PKA in vitro and was determined to be Ser2 by mass spectrometric analysis of the purified chymotryptic phosphopeptide. The PKA sites in NFL were dephosphorylated by the purified catalytic subunit of protein phosphatase-2A but not that of protein phosphatase-1, and phosphoserine-2 was a better substrate than phosphoserine-55. The phosphorylation and dephosphorylation of Ser2 and Ser55 in NFL may therefore be involved in the modulation of neurofilament dynamics through the antagonistic effects of PKA and protein phosphatase-2A.
Asunto(s)
Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Proteínas de Neurofilamentos/metabolismo , Neuronas/metabolismo , Ácido Ocadaico/farmacología , Fragmentos de Péptidos/metabolismo , Secuencia de Aminoácidos , Animales , Activación Enzimática , Ganglios Espinales/citología , Proteínas de Neurofilamentos/química , Neuronas/efectos de los fármacos , Fosfoproteínas Fosfatasas/metabolismo , Fosforilación , Proteína Fosfatasa 1 , Proteína Fosfatasa 2 , RatasRESUMEN
To facilitate studies of the normal biology of alpha-synuclein, a member of a family of neuronal proteins of unknown function, and to elucidate the role of alpha-synuclein pathologies in neurodegenerative diseases, we generated and characterized a panel of anti-synuclein antibodies. Here we demonstrate that these antibodies recognize defined epitopes spanning the entire length of human alpha-synuclein, and that some of these antibodies also cross-react with zebra finch and rodent synucleins. Since alpha-synuclein has been reported to be a major component of Lewy bodies (LBs) in Parkinson's disease (PD), dementia with LBs and common variants of Alzheimer's disease, we performed immunohistochemical studies showing that these antibodies label numerous LBs in the PD substantia nigra, thereby localizing protein domains throughout human alpha-synuclein in LBs. Taken together, our data indicate that this panel of antibodies can be exploited to probe the normal biology of alpha-synuclein as well as the role of pathological forms of this protein in PD and related neurodegenerative synucleinopathies.